Epilepsy Clinical Trials in New York

Showing 21-40 of 127 trials

STXBP1 and SYNGAP1 Related Disorders Natural History Study

NCT06555965

The purpose of this study is to find out more about STXBP1 and SYNGAP1 related disorders. The information gathered by this study will be used to prepare for clinical treatment trials. The primary objective of the study is to better define and outline the clinical spectrum of STXBP1 and SYNGAP1 through detailed developmental, seizure, and quality of life assessments as an extension of routine clinical care.

Genetic DiseaseSTXBP1 Encephalopathy With EpilepsySYNGAP1-Related Intellectual Disability

Children's Hospital of Philadelphia600 participantsStarted Aug 2023

Palo Alto, California, United States • Aurora, Colorado, United States • New York, New York, United States +2 more locations

RECRUITING< 1 mile

Longitudinal Study of Neurogenetic Disorders

NCT03492060

The purpose of this study is to analyze patterns in individuals with hnRNP (and other) genetic variants, including their neurological comorbidities, other medical problems and any treatment. The investigators will maintain an ongoing database of medical data that is otherwise being collected for routine medical care. The investigators will also collect data prospectively in the form of questionnaires, neuropsychological assessments, motor assessments, and electroencephalography to examine the landscape of deleterious variants in these genes.

Neurodevelopmental DisordersIntellectual DisabilityDevelopmental Delay+4 more

Columbia University1,000 participantsStarted Jun 2018

New York, New York, United States

COMPLETEDPhase 3< 1 mile

Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy

NCT01364597

This study will evaluate the safety and tolerability of brivaracetam in pediatric subjects with epilepsy.

Epilepsy

UCB Pharma SA257 participantsStarted Aug 2011

Los Angeles, California, United States • Gulf Breeze, Florida, United States • Wellington, Florida, United States +53 more locations

STXBP1 and SYNGAP1 Related Disorders Natural History Study

Longitudinal Study of Neurogenetic Disorders

Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy

Epilepsy Trials in Other Cities

Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children

The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy

NYU Epilepsy Self-Management Study

RNS System NAUTILUS Study

A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies

Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)

Memory Retrieval and Encoding Investigated by Neural Stimulation

Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures

A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures

RNS System RESPONSE Study

Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.

SLC13A5 Deficiency Natural History Study - United States Only

Prospective Research in Infants With Mild Encephalopathy

Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures

Other Conditions in New York